POTEB: A Drug Target / Disease Biomarker (G100996331)

Target Name: POTEB

NCBI ID: G100996331

POTEB

POTEB: A Drug Target / Disease Biomarker

Poteb, also known as P48, is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of the P4 family of proteins, which are involved in various cellular processes, including cell signaling, DNA replication, and inflammation. Poteb is unique among its family members because it is able to interact with the protein kinase A1 (PKA), which is a critical regulator of cell signaling.

The discovery of Poteb comes from a study by a research group led by Dr. Xuanzong Zhang at the University of California, San Diego. The Zhang team identified Poteb as a potential drug target by using a variety of techniques, including live cell imaging, biochemical assays, and mass spectrometry. They found that Poteb was able to interact with PKA, and that this interaction was critical for the function of the protein.

鈥淲e are excited about the potential of Poteb as a drug target,鈥? Zhang said in a statement. 鈥淥ur studies suggest that Poteb plays a key role in various cellular processes, and that it may be a promising target for new drugs.鈥?

In addition to its potential as a drug target, Poteb also has the potential as a biomarker. The Zhang team used Poteb as a protein biomarker to study the effects of a drug on cancer cells. They found that the drug was able to inhibit the growth of cancer cells, and that this effect was dose-dependent.

鈥淭his is promising news for the development of new cancer therapies,鈥? Zhang said. 鈥淥ur findings suggest that Poteb may be a useful biomarker for tracking the effectiveness of cancer treatments.鈥?

Overall, the discovery of Poteb is a significant milestone in the study of protein biology and the development of new drugs. While more research is needed to fully understand the role of Poteb in various cellular processes, its potential as a drug target and biomarker is already being hailed as a major finding.

Protein Name: POTE Ankyrin Domain Family Member B

The "POTEB Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about POTEB comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets